A Payer's Perspective on the Cost Effectiveness of Gastric Bypass Surgery
Cost-Effectiveness of Roux-en-Y Gastric Bypass in Type 2 Diabetes Patients
A predictive health economic model indicated that Roux-en-Y gastric bypass is cost-effective in the treatment of type 2 diabetes mellitus compared with medical management.
Cost-Effectiveness of Blood Glucose Monitoring Is Controversial
The Importance of Recognizing Patients' Time as a Cost of Self-Management
Self-monitoring of Blood Glucose in Type 2 Diabetes: Cost-effectiveness in the United States
For patients with type 2 diabetes taking oral antidiabetics, self-monitoring of blood glucose cost-effectiveness (1 and 3 times per day) was modeled. Both strategies represented good value in the US payer setting.
Review of the Pharmacoeconomic Research on Gemcitabine in the Treatment of Advanced Non-Small Cell Lung Cancer
2 Clarke Drive Cranbury, NJ 08512